Sorry Jack2479, I don't buy it.
Roger Perlmutter knew about NWBO, their platform and their Ph. III DCVax-L. He was even spotted at the 2019 ASCO the day that NWBO was presenting and talking with LP. Wasn't too soon after later, that NWBO dropped their combo plans with BMY and not much later after that announced combo plans of DCVax-L with Merck's Keytruda.
Too many coincidences for me not to draw my own conclusion that yes Duffy went to NWBO, but, as an agent for Merck. That assignment was complete and he went back to Merck, back to working under Perlmutter. He did his job and now Merck must make their decision (if they haven't already) about if and how to proceed with partnering with NWBO.
The DCVax platform will succeed and will be very successful. It's just who they will partner with going forward. I think both Merck and Roche will combine resources and partner with NWBO. JMHO.
Hans
News 
Market Data 
Discover 
